M.L. Hooper
Impact in
- Oncology top 1%
- Cancer-related Molecular Pathways
- Biotechnology top 1%
- Cancer Research and Treatments
Papers in
-
- Biochemical and Molecular Research 7
- Pluripotent Stem Cells Research 7
- CRISPR and Genetic Engineering 4
- DNA Repair Mechanisms 3
- Genetics 11
- Animal Genetics and Reproduction 5
- Co-authors
- Alan R. Clarke (10 shared papers)David J. Harrison (3 shared papers)Colin A. Purdie (3 shared papers)A H Wyllie (5 shared papers)R. G. Morris (2 shared papers)C C Bird (1 shared paper)Jean Manson (1 shared paper)L Aitchison (1 shared paper)
- Journals
- Experimental Cell Research (14 papers)Development (4 papers)British Journal of Cancer (3 papers)Proceedings of the National Academy of Sciences (2 papers)Oncogene (2 papers)
- Partner nations
- United KingdomCanadaNetherlands
In The Last Decade
M.L. Hooper
42 papers receiving 3.8k citations
M.L. Hooper's Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 1.6k
- Biotechnology 427
- Molecular Biology 2.8k
- Neurology 300
- Cancer Research 381
Countries citing papers authored by M.L. Hooper
This map shows the geographic impact of M.L. Hooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.L. Hooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.L. Hooper more than expected).
Fields of papers citing papers by M.L. Hooper
This network shows the impact of papers produced by M.L. Hooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.L. Hooper. The network helps show where M.L. Hooper may publish in the future.
Co-authors
The 25 scholars most cited alongside M.L. Hooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Thymocyte apoptosis induced by p53-dependent and independent pathways Hit paper breakdown → | 1993 | 1995 |
| 2 | 1994 | 447 | |
| 3 | Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. | 1994 | 257 |
| 4 | 1981 | 118 | |
| 5 | 1991 | 102 | |
| 6 | 1997 | 79 | |
| 7 | 1972 | 74 | |
| 8 | 1993 | 72 | |
| 9 | 1994 | 71 | |
| 10 | 1999 | 67 | |
| 11 | 1991 | 65 | |
| 12 | 1997 | 64 | |
| 13 | K-ras 4A and 4B are co-expressed widely in human tissues, and their ratio is altered in sporadic colorectal cancer. | 2006 | 63 |
| 14 | 1991 | 49 | |
| 15 | 1977 | 43 | |
| 16 | 1977 | 42 | |
| 17 | 1983 | 34 | |
| 18 | 1978 | 24 | |
| 19 | 1991 | 19 | |
| 20 | 1999 | 19 |
About M.L. Hooper
M.L. Hooper is a scholar working on Molecular Biology, Genetics, Oncology, Infectious Diseases and Epidemiology, having authored 43 papers that have together received 3.9k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (7 papers), Pluripotent Stem Cells Research (7 papers), Animal Genetics and Reproduction (5 papers), Cancer-related Molecular Pathways (5 papers), HIV/AIDS drug development and treatment (4 papers), Cytomegalovirus and herpesvirus research (4 papers), CRISPR and Genetic Engineering (4 papers) and DNA Repair Mechanisms (3 papers). The work is most often cited by research in Oncology (1.6k citations), Biotechnology (427 citations), Molecular Biology (2.8k citations), Neurology (300 citations) and Cancer Research (381 citations). M.L. Hooper has collaborated with scholars based in United Kingdom, Canada and Netherlands. Frequent co-authors include Alan R. Clarke, David J. Harrison, Colin A. Purdie, A H Wyllie, R. G. Morris, C C Bird, Jean Manson, L Aitchison, I. McConnell and Jayne C. Hope. Their work appears in journals such as Experimental Cell Research, Development, British Journal of Cancer, Proceedings of the National Academy of Sciences and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.